Schedule 13G ownership disclosure

SALIX PHARMACEUTICALS LTD

Security class unavailable · CUSIP: 795435106

Event date: 2014-08-08

Legacy cover-page extraction is best effort and may not include every reporting person.

Filing-level shares
3,195,153
Percent of class
5.0000%

Amounts are as disclosed in this filing. Schedule type alone does not establish investment intent.

Source: SEC EDGAR filing

Filing metadata

Accession number
0001103804-14-000033
Form type
SC 13G
Filer
SALIX PHARMACEUTICALS LTD
CIK
CIK 1009356
Filed
Aug 14, 2014
Reporting period
Aug 08, 2014
Description
Schedule 13G beneficial ownership

Explore SEC Filings Hub